Clinical Trial Update: A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating different targeted therapies for rheumatoid arthritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Phase 2 | Status: RECRUITING